Prof Jan Steffel (Univerity Heart Center, Zurich, CH), Prof Jur ten Berg (St Anthonius Hospital, Nieuwegein, NL) and Prof Stefan Hohnloser (JW Goethe University, Frankfurt, DE) discuss Dual vs Triple Anti-thrombotic Therapy for Post-PCI Patients with Atrial Fibrillation - trials and the differences.
Video
PART 2: Dual vs Triple Anti-thrombotic Therapy for Post-PCI Patients with Atrial Fibrillation - Trials and the Differences
Published: 21 May 2020
-
Views:
258 -
Likes:
0